Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07852065 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

iTBS Versus Standard 10 Hz rTMS for Treatment-Resistant Depression (TRD)

Study acronym: iTBS-TRD
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
This randomised, parallel-group, non-inferiority trial compared intermittent theta burst stimulation (iTBS, 3-minute sessions) with standard 10 Hz repetitive transcranial magnetic stimulation (rTMS, 37-minute sessions) applied to the left dorsolateral prefrontal cortex (DLPFC) in adults with treatment-resistant depression (TRD). Participants received 20 sessions over 4 weeks. The primary aim was to determine whether iTBS is non-inferior to standard rTMS in reducing depressive symptoms (HDRS-17) at Week 4, and to compare patient-reported treatment experience and acceptability between protocols.
Trial Details
NCT Number NCT07852065
Lead Sponsor Kafrelsheikh University
Conditions
(from sponsor)		 Major Depression
Related terms Depressive Disorder, Treatment-Resistant, Major Depressive Disorder
Enrollment 182 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov